Swog S1826: A Phase Iii, Randomized Study Of Nivolumab Plus Avd Or Brentuximab Vedotin Plus Avd In Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

BLOOD(2020)

引用 12|浏览54
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要